NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Serina Therapeutics, Inc. Share Price Chart

O H L

Serina Therapeutics, Inc. Performance Overview

Days Range
$2.24Low
$2.24High

Markets Today

Previous Close$2.22
Open$2.24
Volume30,040
Day's Range$2.24 - $2.24
52W Range$1.22 - $5.83
Market Cap$54.87 M

Historical Performance

1M Returns-15.27
3M Returns+5.71
6M Returns+73.44
1Y Returns-50.78
5Y ReturnsNA
10Y ReturnsNA

Serina Therapeutics, Inc. Fundamentals

Market Cap$54.87 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$130.00 K
ROE TTMN/A
EPS TTM$-1.88
Quarterly Earnings Growth YOYN/A
PB Ratio2.93
EBITDA$-23.95 M
Profit Margin-14950.77
Market Cap$54.87 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$130.00 K
ROE TTMN/A
EPS TTM$-1.88
Quarterly Earnings Growth YOYN/A
PB Ratio2.93
EBITDA$-23.95 M
Profit Margin-14950.77

Serina Therapeutics, Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$130.00 K$0$0$0$0
Gross Profit +$0$130.00 K$0$0$0$0
Operating Income -$5.86 M-$5.57 M-$6.39 M-$6.21 M-$6.28 M-$6.78 M
EBITDA -$5.84 M-$5.55 M-$6.38 M-$6.18 M-$6.26 M-$6.77 M
Interest Expense $0-$9.00 K-$6.00 K-$198.00 K-$189.00 K-$203.00 K
Depreciation $17.00 K$16.00 K$16.00 K$24.00 K$18.00 K$18.00 K
Income Before Tax -$4.82 M-$6.46 M-$4.59 M-$3.32 M-$6.89 M-$6.36 M
Income Tax Expense $0$0$0$18.00 K$7.00 K$0
Net Income +-$4.82 M-$6.46 M-$4.59 M-$3.34 M-$6.90 M-$6.36 M
Net Profit Margin --4970.77%----

Serina Therapeutics, Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $1.00 K$1.00 K$1.00 K$1.00 K$1.00 K$3.00 K
Reserve & Surplus -$49.13 M-$55.58 M-$60.17 M-$63.51 M-$70.41 M-$76.75 M
Non-Current Liabilities $2.82 M$3.73 M$2.03 M$3.42 M$3.33 M$3.32 M
Current Liabilities $2.35 M$3.56 M$8.79 M$3.56 M$6.34 M$3.76 M
Total Liabilities $5.17 M$7.29 M$10.82 M$6.99 M$9.67 M$7.08 M
Fixed Assets $484.00 K$588.00 K$580.00 K$465.00 K$472.00 K$482.00 K
Current Assets $5.75 M$7.99 M$11.50 M$6.08 M$26.47 M$25.03 M
Total Assets $6.73 M$8.94 M$12.41 M$6.95 M$27.30 M$25.81 M

Serina Therapeutics, Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$4.82 M-$6.46 M-$4.59 M-$3.34 M-$6.90 M-$6.36 M
Operating Cash Flow -$4.32 M-$3.75 M-$3.85 M-$6.03 M-$4.57 M-$6.68 M
Investing Cash Flow $0-$46.00 K-$13.00 K$0-$25.00 K-$28.00 K
Financing Cash Flow $4.92 M$5.57 M$6.44 M$481.00 K$26.06 M$5.20 M
Change in Cash $595.00 K$1.77 M$2.58 M-$5.56 M$21.47 M-$1.50 M

Serina Therapeutics, Inc. Return Calculator

The Serina Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Serina Therapeutics, Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

FAQs

Serina Therapeutics, Inc. (SER) share price as of September 18, 2026 is $2.15. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Serina Therapeutics, Inc. (SER) Share by opening an international trading account with Angel One.
Purchasing Serina Therapeutics, Inc. (SER) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Serina Therapeutics, Inc. (SER) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Serina Therapeutics, Inc. (SER) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Serina Therapeutics, Inc. on September 18, 2026, is $54.87 M.
Serina Therapeutics, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Serina Therapeutics, Inc. (SER) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91